• Explore /
  • Poster
  • / Baseline circulating soluble factors as predictors of immune-related adverse events (irAEs) in patients (pts) with metastatic clear cell renal carcinoma (mRCC) treated with nivolumab: A translational NIVOREN GETUG-AFU 26 study.

Baseline circulating soluble factors as predictors of immune-related adverse events (irAEs) in patients (pts) with metastatic clear cell renal carcinoma (mRCC) treated with nivolumab: A translational NIVOREN GETUG-AFU 26 study.

Abstract Poster

Authors

null

Lucia Carril-Ajuria

Medical Oncology, Institute Gustave Roussy, Villejuif, France

Lucia Carril-Ajuria , Marie Naigeon , Cécile Dalban , Aude Desnoyer , Nathalie Rioux-Leclercq , Catherine Sautès-Fridman , Maxime Meylan , Yann-Alexandre Vano , Benoit Beusenlick , Salem Chouaib , Caroline de Oliveira , Florence Tantot , Ronan Flippot , Bernard Escudier , Laurence Albiges , Nathalie Chaput

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 724)

DOI

10.1200/JCO.2023.41.6_suppl.724

Abstract #

724

Poster Bd #

K19

Abstract Disclosures

Similar Posters

First Author: Lucia Carril-Ajuria

First Author: Lucia Carril

First Author: Fengnian Zhao

First Author: Thomas Hilser